Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

Walgreens Boots Alliance's prospective sale to a private equity firm is " mostly dead ," sources told CNBC's David Faber, according to a Jan. 27 report from The Wall Street Journal. Here are five ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Sycamore is a private equity firm based in New York. The firm specializes in consumer, distribution and retail-related investments. No financial terms were disclosed.

Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...

Meanwhile, analysts believe Walgreens is turning the corner without the help of private equity. "Walgreens ... that the rumored sale to PE firm Sycamore Partners is less likely." ...

Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...

Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...

This is apparently happening to Walgreens Boots Alliance (NASDAQ: WBA), according to a media report. CNBC's David Faber ...